Literature DB >> 28162841

Adherence to Attention-Deficit/Hyperactivity Disorder Medication During the Transition to College.

Megan R Schaefer1, Alana Resmini Rawlinson2, Scott T Wagoner2, Steven K Shapiro2, Jan Kavookjian3, Wendy N Gray2.   

Abstract

PURPOSE: The present study explores the medication self-management experiences of adolescents with attention-deficit/hyperactivity disorder (ADHD) during their transition to young adulthood in college.
METHODS: Participants were college freshmen with ADHD prescribed daily medication for their condition. Ten individual interviews were conducted using a semistructured interview script. Measures related to ADHD medication management were also completed. Qualitative data were analyzed via directed content analysis and quantitative data via descriptive statistics.
RESULTS: Five themes emerged from interviews: (1) transitions to independence are often abrupt, and many adolescents lack critical self-management skills; (2) volitional nonadherence is high due to inaccurate disease beliefs, perceived academic demands, and medication side effects; (3) poor self-management negatively impacts school performance; (4) peer pressure to share medication affects social functioning and adherence; and (5) social support is greatly needed. Common barriers to adherence included "don't feel like taking medication" (90%) and "difficulties in sticking to a fixed medication schedule" (80%).
CONCLUSIONS: Participants with ADHD were not prepared to manage their chronic illness independently in context of increased demands and newfound freedom, resulting in negative academic consequences. Social factors also play an influential role in ADHD self-management, particularly related to the isolation associated with sharing the medication and its side effects. Intervention programs targeting medication self-management during the transition to independence are greatly needed for young adults with ADHD as high academic performance in college is critical for future success.
Copyright © 2016 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adherence; Adolescent; Attention-deficit/hyperactivity disorder; Self-management; Transition; Young adult

Mesh:

Year:  2017        PMID: 28162841     DOI: 10.1016/j.jadohealth.2016.12.011

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  6 in total

1.  How to say "no" most effectively: Evaluating resistance strategies for prescription stimulant diversion to inform preventive interventions.

Authors:  Laura J Holt; Ty S Schepis; Alison Looby; Eliza Marsh; Paige Marut; Richard Feinn
Journal:  J Am Coll Health       Date:  2019-06-26

Review 2.  New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development.

Authors:  David J Heal; Jane Gosden; Sharon L Smith
Journal:  Curr Top Behav Neurosci       Date:  2022

3.  Responsibility for Asthma Management Among Adolescents With and Without Attention-Deficit/Hyperactivity Disorder.

Authors:  Andrea Milne Wenderlich; Constance D Baldwin; Maria Fagnano; Marybeth Jones; Jill Halterman
Journal:  J Adolesc Health       Date:  2019-08-02       Impact factor: 5.012

4.  In transition with ADHD: the role of information, in facilitating or impeding young people's transition into adult services.

Authors:  Anna Price; Tamsin Newlove-Delgado; Helen Eke; Moli Paul; Susan Young; Tamsin Ford; Astrid Janssens
Journal:  BMC Psychiatry       Date:  2019-12-17       Impact factor: 3.630

5.  Unmet care needs of children with ADHD.

Authors:  Richard Vijverberg; Robert Ferdinand; Aartjan Beekman; Berno van Meijel
Journal:  PLoS One       Date:  2020-01-17       Impact factor: 3.240

6.  Why young people stop taking their attention deficit hyperactivity disorder medication: A thematic analysis of interviews with young people.

Authors:  Daniel Titheradge; Jo Godfrey; Helen Eke; Anna Price; Tamsin Ford; Astrid Janssens
Journal:  Child Care Health Dev       Date:  2022-02-20       Impact factor: 2.943

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.